Daphne Quimi - 31 Dec 2021 Form 4 Insider Report for AMICUS THERAPEUTICS, INC. (FOLD)

Role: Chief Financial Officer
Signature: /s/ Christian Formica, Attorney-in-Fact
Issuer symbol: FOLD
Transactions as of: 31 Dec 2021
Net transactions value: -$372,591
Form type: 4
Filing time: 04 Jan 2022, 20:01:33 UTC
Next filing: 10 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FOLD	Common Stock	Tax liability	$121,298	-10,502	-3.6%	$11.55	280,127	31 Dec 2021	Direct
transaction	FOLD	Common Stock	Tax liability	$182,236	-15,778	-5.6%	$11.55	264,349	02 Jan 2022	Direct
transaction	FOLD	Common Stock	Tax liability	$18,625	-1,538	-0.58%	$12.11	262,811	03 Jan 2022	Direct
transaction	FOLD	Common Stock	Award		+73,136	+28%		335,947	03 Jan 2022	Direct	F1, F2
transaction	FOLD	Common Stock	Tax liability	$50,432	-4,041	-1.2%	$12.48	331,906	04 Jan 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FOLD	Stock Options (right to buy)	Award	$0	+134,044		$0.000000	134,044	03 Jan 2022	Common Stock	134,044	$12.11	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Granted in the form of Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Amicus common stock.
F2	The Restricted Stock Units will vest in four equal annual installments beginning on January 3, 2023.
F3	These options vest and become exercisable in a series of installments over a four year period with 25% vesting one year after the date of grant and the remaining 75% vesting ratably each month thereafter.